Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

被引：0
|
作者：
Andrea Guttilla
Roberto Bortolus
Gianluca Giannarini
Pirus Ghadjar
Fabio Zattoni
Michele Gnech
Vito Palumbo
Francesca Valent
Antonio Garbeglio
Filiberto Zattoni
机构：
[1] Urology Clinic University of Padua,Department of Oncological, Surgical and Gastroenterological Sciences
[2] National Cancer Institute Aviano,Department of Radiation Oncology
[3] University of Bern,Department of Urology
[4] Inselspital,Department of Radiation Oncology
[5] University of Bern,Epidemiological Service, Direzione Centrale Salute, Integrazione Sociosanitaria e Politiche Sociali
[6] Inselspital,Department of General Surgery, Division of Urology
[7] Regione Autonoma Friuli Venezia Giulia,undefined
[8] Azienda Ospedaliera “Santa Maria degli Angeli”,undefined
来源：
Radiation Oncology | / 9卷
关键词：
Prostatic neoplasms; Radiotherapy; Intensity-modulated; Prostatectomy; Androgen deprivation therapy; Chemotherapy; Docetaxel; Toxicity; Clinical trial; Phase II;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial
    Guttilla, Andrea
    Bortolus, Roberto
    Giannarini, Gianluca
    Ghadjar, Pirus
    Zattoni, Fabio
    Gnech, Michele
    Palumbo, Vito
    Valent, Francesca
    Garbeglio, Antonio
    Zattoni, Filiberto
    RADIATION ONCOLOGY, 2014, 9
  • [2] Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer
    Chen, Ronald C.
    Rosenman, Julian G.
    Hoffman, Leroy G.
    Chiu, Wing-Keung
    Wang, Andrew Z.
    Pruthi, Raj S.
    Wallen, Eric M.
    Crane, Jeffrey M.
    Kim, William Y.
    Rathmell, W. Kimryn
    Godley, Paul A.
    Whang, Young E.
    BJU INTERNATIONAL, 2012, 110 (11B) : E721 - E726
  • [3] Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer
    Lin, Jianqing
    Den, Robert B.
    Greenspan, Jacob
    Showalter, Timothy N.
    Hoffman-Censits, Jean H.
    Lallas, Costas D.
    Trabulsi, Edouard J.
    Gomella, Leonard G.
    Hurwitz, Mark D.
    Leiby, Benjamin
    Dicker, Adam P.
    Kelly, W. Kevin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 939 - 947
  • [4] Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer
    Vuky, Jacqueline
    Pham, Huong T.
    Warren, Sarah
    Douglass, Erika
    Badiozamani, Kasra
    Madsen, Berit
    Hsi, Alex
    Song, Guobin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : E609 - E615
  • [5] Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer
    Zelefsky, Michael J.
    Chan, Heather
    Hunt, Margie
    Yamada, Yoshiya
    Shippy, Alison M.
    Amols, Howard
    JOURNAL OF UROLOGY, 2006, 176 (04): : 1415 - 1419
  • [6] Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate-risk and high-risk prostate cancer
    Kobayashi, Masayuki
    Hatano, Kazuo
    Fukasawa, Satoshi
    Komaru, Atsushi
    Namekawa, Takeshi
    Imagumbai, Toshiyuki
    Araki, Hitoshi
    Hara, Ryusuke
    Ichikawa, Tomohiko
    Ueda, Takeshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (05) : 477 - 482
  • [7] Adjuvant High-Dose Intensity-Modulated Radiotherapy after Radical Prostatectomy for Prostate Cancer: Clinical Results in 104 Patients
    Ost, Piet
    Fonteyne, Valerie
    Villeirs, Geert
    Lumen, Nicolaas
    Oosterlinck, Willem
    De Meerleer, Gert
    EUROPEAN UROLOGY, 2009, 56 (04) : 669 - 675
  • [8] Hypofractionated High-Dose Radiation Therapy for Prostate Cancer: Long-Term Results of a Multi-Institutional Phase II Trial
    Fonteyne, Valerie
    Soete, Guy
    Arcangeli, Stefano
    De Neve, Wilfried
    Rappe, Bernard
    Storme, Guy
    Strigari, Lidia
    Arcangeli, Giorgio
    De Meerleer, Gert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (04): : E483 - E490
  • [9] Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
    Aizawa, Rihito
    Takayama, Kenji
    Nakamura, Kiyonao
    Inoue, Takahiro
    Yamasaki, Toshinari
    Kobayashi, Takashi
    Akamatsu, Shusuke
    Ogawa, Osamu
    Mizowaki, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (10) : 1247 - 1255
  • [10] Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
    McKay, Rana R.
    Xie, Wanling
    Ye, Huihui
    Fennessy, Fiona M.
    Zhang, Zhenwei
    Lis, Rosina
    Calagua, Carla
    Rathkopf, Dana
    Laudone, Vincent P.
    Bubley, Glenn J.
    Einstein, David J.
    Chang, Peter K.
    Wagner, Andrew A.
    Parsons, J. Kellogg
    Preston, Mark A.
    Kilbridge, Kerry
    Chang, Steven L.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Trinh, Quoc-Dien
    Kibel, Adam S.
    Taplin, Mary-Ellen
    JOURNAL OF UROLOGY, 2021, 206 (01): : 80 - 87
12345